Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Carcinoma Non-small Cell Lung Cancer Stage IIIB”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Ended earlyNCT00551733
What this trial is testing

Carboplatin With Either Paclitaxel Poliglumex or Paclitaxel in Treating Women With Stage IIIB, Stage IV, or Recurrent Non-Small Cell Lung Cancer

Who this might be right for
Lung Cancer
CTI BioPharma 450
Large-scale testing (Phase 3)Looking for participantsNCT07016126
What this trial is testing

D-BACE in Combination With Chemotherapy and Carelizumab for Resectable II-IIIA or Potentially Resectable T3-4N2 Stage IIIB NSCLC

Who this might be right for
NSCLC (Non-small Cell Lung Cancer)
Guangdong Provincial People's Hospital 70
Testing effectiveness (Phase 2)Study completedNCT00041314
What this trial is testing

Combination Chemotherapy in Treating Patients With Advanced Non-Small Cell Lung Cancer

Who this might be right for
Lung Cancer
Eastern Cooperative Oncology Group
Testing effectiveness (Phase 2)Study completedNCT00005037
What this trial is testing

Temozolomide in Treating Patients With Stage IIIB, Stage IV, or Recurrent Non-small Cell Lung Cancer

Who this might be right for
Lung Cancer
Fox Chase Cancer Center 51
Not applicableStudy completedNCT00900302
What this trial is testing

OX-40 Protein Expression in the Sentinel Lymph Nodes of Patients With Cancer

Who this might be right for
Cancer
OHSU Knight Cancer Institute 98
Testing effectiveness (Phase 2)Study completedNCT02599194
What this trial is testing

18F-FSPG PET/CT for Cancer Patients on Therapy

Who this might be right for
B-Cell NeoplasmEstrogen Receptor NegativeHER2/Neu Negative+13 more
Andrei Iagaru 7
Testing effectiveness (Phase 2)Looking for participantsNCT03191149
What this trial is testing

Testing Osimertinib as a Treatment for Lung Cancers With an EGFR Exon 20 Change

Who this might be right for
Advanced Lung Non-Small Cell CarcinomaRecurrent Lung Non-Small Cell CarcinomaStage IIIB Lung Non-Small Cell Cancer AJCC v7+1 more
National Cancer Institute (NCI) 46
Testing effectiveness (Phase 2)Study completedNCT00078390
What this trial is testing

Study of S-3304 in Patients With Locally Advanced Non-Small Cell Lung Cancer

Who this might be right for
Non Small Cell Lung CancerLung CancerStage IIIA Non Small Cell Lung Cancer+1 more
Shionogi 9
Testing effectiveness (Phase 2)Ended earlyNCT00559897
What this trial is testing

Zoledronic Acid and Positron Emission Tomography in Treating Patients With Advanced Non-Small Cell Lung Cancer

Who this might be right for
Lung CancerMetastatic Cancer
Barbara Ann Karmanos Cancer Institute 6
Testing effectiveness (Phase 2)Study completedNCT03735095
What this trial is testing

Endobronchial Ultrasound Guided Interstitial Photodynamic Therapy in Treating Patients With Locally Advanced Lung Cancer

Who this might be right for
Locally Advanced Lung CarcinomaNon-Small Cell Lung CarcinomaSmall Cell Lung Carcinoma+5 more
Roswell Park Cancer Institute 19
Testing effectiveness (Phase 2)Looking for participantsNCT07039656
What this trial is testing

Toripalimab Combined With Chemotherapy as Adjuvant Therapy for Non-small Cell Lung Cancer With or Without Prior Neoadjuvant Therapy

Who this might be right for
Stage IB-IIIB NSCLCStage IIB-III NSCLC
Wen-zhao ZHONG 211
Testing effectiveness (Phase 2)Ended earlyNCT02959437
What this trial is testing

Azacitidine Combined With Pembrolizumab and Epacadostat in Subjects With Advanced Solid Tumors (ECHO-206)

Who this might be right for
Solid TumorsAdvanced MalignanciesMetastatic Cancer
Incyte Corporation 70
Early research (Phase 1)Ended earlyNCT02298153
What this trial is testing

Atezolizumab in Combination With Epacadostat in Subjects With Previously Treated Stage IIIB or Stage IV Non-Small Cell Lung Cancer and Previously Treated Stage IV Urothelial Carcinoma

Who this might be right for
NSCLC (Non-small Cell Lung Carcinoma)UC (Urothelial Cancer)
Incyte Corporation 29
Large-scale testing (Phase 3)Study completedNCT01814553
What this trial is testing

ADAM-Afatinib Diarrhea Assessment and Management

Who this might be right for
Carcinoma, Non-Small-Cell Lung
Boehringer Ingelheim 40
Testing effectiveness (Phase 2)UnknownNCT00828022
What this trial is testing

Measles Vaccine in Patients With Measles Virus-Positive, Advanced Non-Small Cell Lung Cancer

Who this might be right for
Non-Small Cell Lung CancerMeasles
Soroka University Medical Center 15
Testing effectiveness (Phase 2)Study completedNCT00137800
What this trial is testing

Study of OSI-774 (Tarceva) in Previously Untreated Elderly Lung Cancer Patients

Who this might be right for
Non-Small-Cell Lung Carcinoma
Dana-Farber Cancer Institute 82
Testing effectiveness (Phase 2)Study completedNCT00436332
What this trial is testing

S0635: Erlotinib and Bevacizumab in Stage IIIB and IV Bronchioloalveolar Carcinoma

Who this might be right for
Lung Cancer
SWOG Cancer Research Network 84
Testing effectiveness (Phase 2)Study completedNCT00771953
What this trial is testing

0822GCC: Phase 2 Study of Efficacy and Safety of Apricoxib/Placebo With Docetaxel or Pemetrexed in Non-Small Cell Lung Cancer

Who this might be right for
Lung CancerNon Small Cell Lung Cancer
University of Maryland, Baltimore 109
Not applicableStudy completedNCT00433407
What this trial is testing

T-Cell Response in Patients Receiving Trastuzumab and/or Chemotherapy for HER2-Positive Solid Tumors

Who this might be right for
Breast CancerLung CancerOvarian Cancer+3 more
Jonsson Comprehensive Cancer Center 12
Large-scale testing (Phase 3)WithdrawnNCT00090675
What this trial is testing

Maintenance ZD1839 (IRESSA®) Following Completion of Front Line, Platinum-Based, Double Chemotherapy in Subjects With Advanced or Metastatic Non-Small Cell Lung Cancer

Who this might be right for
Non-Small-Cell Lung Carcinoma
AstraZeneca
Next Page